Search results
Lilly's (LLY) Migraine Drug Fails Vis-a-Vis Pfizer's Nurtec ODT
Zacks via Yahoo Finance· 11 months agoResults from a post-approval study show that treatment with Lilly's (LLY) Emgality failed to achieve...
Eli Lilly ordered to pay $176.5 million to Teva in U.S. migraine drug patent trial
Reuters via Yahoo Finance· 2 years agoEli Lilly & Co must pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to...
Eli Lilly (LLY) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 7 months agoEli Lilly & Company LLY will report third-quarter 2023 results on Nov 2, before market open. In the...
Eli Lilly's migraine drug fails to prove superiority to Pfizer's
Reuters via Yahoo News· 11 months agoThe three-month study, which involved 580 patients, was the first-of-its-kind to compare the two...
Eli Lilly's Migraine Candidate Flunks Head-To-Head Study With Pfizer's Newly Acquired Drug
Benzinga via Yahoo Finance· 11 months agoEli Lilly And Co (NYSE: LLY) announced the results of the CHALLENGE-MIG clinical trial of Emgality...
Eli Lilly (LLY) to Report Q1 Earnings: Will It Beat Estimates?
Zacks via Yahoo Finance· 1 year agoWe expect Eli Lilly & Company LLY to beat expectations when it reports first-quarter 2023 results on...
Drug/Biotech Stocks' Q3 Earnings on Nov 1: PFE, LLY & More
Zacks via Yahoo Finance· 2 years agoThe third-quarter earnings season is in full swing for the drug and biotech sector. Several large...
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
Reuters via Yahoo Finance· 8 months agoDrugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5...
Lilly launches online service for home delivery of weight loss drug
BioPharma Dive via Yahoo Finance· 5 months agoThe new program, dubbed LillyDirect, will help patients connect with telehealth providers and...
Eli Lilly (LLY) Q2 Earnings Beat, Mounjaro Powers Sales Growth
Zacks via Yahoo Finance· 10 months agoEli Lilly and Company LLY reported second-quarter 2023 adjusted earnings per share of $2.11, which...